截肢后疼痛:随机对照试验的综合分析,评估阿片类药物和 gabapentinoids 与安慰剂
Adam Arthur1,2, Leonardo Kapural3, Richard P Chiacchierini4
1Department of Neurological Surgery, Semmes-Murphey Neurologic and Spine Institute, Memphis, TN, USA.
Journal of pain research
|October 29, 2024
概括
近50%的截肢者经历了长期的术后阿片类药物使用. 这项研究比较了吗啡和 gabapentin 对截肢后的疼痛,发现两者都是有效的,但强调了需要长期研究.
科学领域:
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
- 外科手术的结果
背景情况:
- 截肢截肢每年影响美国约185,000名患者.
- 近50%的截肢者经历了长期的术后阿片类药物使用 (90-180天).
- 手术前使用类药物,肌肉松剂,抗药和抗抑郁药与长时间使用阿片类药物有关,这表明需要新的策略.
研究的目的:
- 评估在治疗截肢后疼痛方面选择的药理学药物的疗效.
- 评估截肢者现有的疼痛管理策略的成功率.
主要方法:
- 选PubMed随机对照试验 (RCT) 涉及 gabapentinoids (gabapentin,pregabalin) 或阿片类药物 (吗啡).
- 从质量上比较了两个吗啡RCT和两个 gabapentin试验与安慰剂.
- 在4至6周的急性期内分析了截肢后的疼痛.
主要成果:
- 吗啡比安慰剂 (P=0.02) 具有统计学显著的治疗效果,治疗所需数量 (NNT) 为3.9.
- 加巴丁也显示出比安慰剂显著的效果,估计NNT为8.9.
- 这两种药物都在4至6周的急性截肢后期进行了评估.
结论:
- 经历肢体截肢的患者对有效的慢性疼痛控制有重大未满足的需求.
- 该研究强调需要进行更大规模,更长期的受控试验,以评估截肢者慢性加巴类药物和阿片类药物的使用情况.
- 进一步的研究至关重要,以了解这些药物的长期益处和风险,以管理慢性截肢后疼痛.
相关概念视频
Analgesia and Pain Management
534
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
534
Opioid Analgesics: Synthetic and Semisynthetic Opioids
234
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
234


